Sir,-There has been much recent interest in the mechanisms which underlie adverse reactions to i.v. anaesthetic drugs. Watkins and colleagues (1976) have shown convincingly that complement activation via the alternate pathway is a frequent mechanism underlying the adverse reaction to Althesin. It is less certain, however, which other drugs can activate the alternate complement pathway.
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We would like to report a severe reaction in a healthy 26-yr-old man undergoing cautery of nasal mucosa and catheterization of the right eustachean tube. There was no history of allergy other than nasal stuffiness which was aggravated by exposure to grass cuttings. More than 20 years ago he had been anaesthetized for the treatment of an upper limb fracture; details of the drugs used are not available, and he had not received anaesthesia on any other occasion.
The patient had an immediate histamine-mediated reaction causing profound and prolonged hypotension after gallamine 20 mg, thiopentone 450 mg and suxamethonium 125 mg i.v. Loss of circulating blood volume responded to the infusion of plasma and the vigorous application of conventional resuscitation measures. Serial blood samples showed massive conversion of complement C3 via the alternate pathway. Three hours after the start of the reaction 60% of the C3 complement had undergone conversion, which is greater than has ever been recorded after an Althesin reaction.
We conclude that gallamine, thiopentone and suxamethonium in combination, and perhaps individually, may trigger the alternate complement pathway in a susceptible individual, with life-threatening consequences. 
AMETHOCAINE
Sir,-Dr Crawford mentioned the use of hyperbaric solutions of cinchocaine, lignocaine and prilocaine (Crawford, 1979) . Many anaesthetists who have used amethocaine for spinal anaesthesia consider it to be superior to these drugs and would greatly value its availability in this country. Why are drug companies reluctant to market a suitable preparation of amethocaine in Britain ? Approaches to drug marketing concerns reap no harvest, and little explanation is given for this negative response. Could it be that the quantity used would be inadequate to justify the expensive and time-consuming process of reintroducing the drug ? It seems so unsatisfactory that we should import disposable spinal anaesthesia sets from the U.S.A. with empty slots from which amethocaine ampoules have been removed! Amethocaine survives well the process of sterilization by autoclaving (Bridenbaugh and Moore, 1964) . Ampoules containing the dry salt are particularly stable, and are readily mixed with dextrose solution to produce hyperbaric or hypobaric solutions suitable for subarachnoid administration.
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